Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Gutmann

Showing results (131-140 of 434) with videos related to

Pageof 44
Sort By:
Oncogene|February 22, 2002
Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivoZhi-yong Huang, Rebecca L Baldwin, Nicolé M Hedrick, et al.
The Lancet. Neurology|December 16, 2014
A multidisciplinary approach in neurofibromatosis 1--authors' replyJonathan A Epstein, David A Ingram, Angela C Hirbe, et al.
Journal of Sleep Research|January 5, 2019
Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentationCorina Anastasaki, Nicholas Rensing, Kevin J Johnson, et al.
The Journal of Pain|April 13, 2013
Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1Daniel E O'Brien, Daniel S Brenner, David H Gutmann, et al.
Oncotarget|April 6, 2017
Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survivalYuan Pan, Laura J Smithson, Yu Ma, et al.
Molecular Cancer Therapeutics|January 11, 2011
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytesSutapa Banerjee, Scott M Gianino, Feng Gao, et al.
Journal of the American Academy of Dermatology|April 2, 2014
Glomus tumors in individuals with neurofibromatosis type 1Monique G Kumar, Ryan J Emnett, Susan J Bayliss, et al.
Cancer Research|June 5, 2003
Mouse models of human cancer consortium symposium on nervous system tumorsDavid H Gutmann, Suzanne J Baker, Marco Giovannini, et al.
Plos One|March 6, 2014
In vivo functional analysis of the human NF2 tumor suppressor gene in DrosophilaHeather S Gavilan, Rima M Kulikauskas, David H Gutmann, et al.
Journal of Child Neurology|November 26, 2004
Tuberous sclerosis complex: pathogenesis, diagnosis, strategies, therapies, and future research directionsBernard L Maria, Kathleen McCann Deidrick, E Steve Roach, et al.
Pageof 44

Showing results (131-140 of 434) with videos related to

Sort By:
Pageof 44
Oncogene|February 22, 2002
Astrocyte-specific expression of CDK4 is not sufficient for tumor formation, but cooperates with p53 heterozygosity to provide a growth advantage for astrocytes in vivoZhi-yong Huang, Rebecca L Baldwin, Nicolé M Hedrick, et al.
The Lancet. Neurology|December 16, 2014
A multidisciplinary approach in neurofibromatosis 1--authors' replyJonathan A Epstein, David A Ingram, Angela C Hirbe, et al.
Journal of Sleep Research|January 5, 2019
Neurofibromatosis type 1 (Nf1)-mutant mice exhibit increased sleep fragmentationCorina Anastasaki, Nicholas Rensing, Kevin J Johnson, et al.
The Journal of Pain|April 13, 2013
Assessment of pain and itch behavior in a mouse model of neurofibromatosis type 1Daniel E O'Brien, Daniel S Brenner, David H Gutmann, et al.
Oncotarget|April 6, 2017
Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survivalYuan Pan, Laura J Smithson, Yu Ma, et al.
Molecular Cancer Therapeutics|January 11, 2011
Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytesSutapa Banerjee, Scott M Gianino, Feng Gao, et al.
Journal of the American Academy of Dermatology|April 2, 2014
Glomus tumors in individuals with neurofibromatosis type 1Monique G Kumar, Ryan J Emnett, Susan J Bayliss, et al.
Cancer Research|June 5, 2003
Mouse models of human cancer consortium symposium on nervous system tumorsDavid H Gutmann, Suzanne J Baker, Marco Giovannini, et al.
Plos One|March 6, 2014
In vivo functional analysis of the human NF2 tumor suppressor gene in DrosophilaHeather S Gavilan, Rima M Kulikauskas, David H Gutmann, et al.
Journal of Child Neurology|November 26, 2004
Tuberous sclerosis complex: pathogenesis, diagnosis, strategies, therapies, and future research directionsBernard L Maria, Kathleen McCann Deidrick, E Steve Roach, et al.
Pageof 44